Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2019 1
2020 1
2021 5
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Synthesis and biological activity of 21,22-cyclosteroids and their derivatives.
Barysevich MV, Laktsevich-Iskryk MV, Scherbakov AM, Salnikova DI, Andreeva OE, Sorokin DV, Shchegolev YY, Hurski AL, Zhabinskii VN, Khripach VA. Barysevich MV, et al. Among authors: sorokin dv. Steroids. 2022 Dec;188:109135. doi: 10.1016/j.steroids.2022.109135. Epub 2022 Nov 3. Steroids. 2022. PMID: 36336105
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance.
Krymov SK, Scherbakov AM, Dezhenkova LG, Salnikova DI, Solov'eva SE, Sorokin DV, Vullo D, De Luca V, Capasso C, Supuran CT, Shchekotikhin AE. Krymov SK, et al. Among authors: sorokin dv. Pharmaceuticals (Basel). 2022 Nov 23;15(12):1453. doi: 10.3390/ph15121453. Pharmaceuticals (Basel). 2022. PMID: 36558903 Free PMC article.
Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway.
Zapevalova MV, Shchegravina ES, Fonareva IP, Salnikova DI, Sorokin DV, Scherbakov AM, Maleev AA, Ignatov SK, Grishin ID, Kuimov AN, Konovalova MV, Svirshchevskaya EV, Fedorov AY. Zapevalova MV, et al. Among authors: sorokin dv. Int J Mol Sci. 2022 Sep 17;23(18):10854. doi: 10.3390/ijms231810854. Int J Mol Sci. 2022. PMID: 36142768 Free PMC article.
Effective synthesis of novel dihydrobenzisoxazoles bearing the 2-aminothiazole moiety and evaluation of the antiproliferative activity of their acylated derivatives.
Piven YA Dr, Scherbakov AM Dr, Yastrebova MA, Sorokin DV, Shchegolev YY, Matous AE, Zinovich VG Dr, Khlebnicova TS Dr, Lakhvich FA Dr. Piven YA Dr, et al. Among authors: sorokin dv. Org Biomol Chem. 2021 Dec 8;19(47):10432-10443. doi: 10.1039/d1ob01614h. Org Biomol Chem. 2021. PMID: 34846407
Secretion of Mutant DNA and mRNA by the Exosomes of Breast Cancer Cells.
Andreeva OE, Shchegolev YY, Scherbakov AM, Mikhaevich EI, Sorokin DV, Gudkova MV, Bure IV, Kuznetsova EB, Mikhaylenko DS, Nemtsova MV, Bagrov DV, Krasil'nikov MA. Andreeva OE, et al. Among authors: sorokin dv. Molecules. 2021 Apr 25;26(9):2499. doi: 10.3390/molecules26092499. Molecules. 2021. PMID: 33922925 Free PMC article.
Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold.
Krymov SK, Scherbakov AM, Salnikova DI, Sorokin DV, Dezhenkova LG, Ivanov IV, Vullo D, De Luca V, Capasso C, Supuran CT, Shchekotikhin AE. Krymov SK, et al. Among authors: sorokin dv. Eur J Med Chem. 2022 Jan 15;228:113997. doi: 10.1016/j.ejmech.2021.113997. Epub 2021 Nov 17. Eur J Med Chem. 2022. PMID: 34902732
Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI, Scherbakov AM, Dezhenkova LG, Bykov EE, Solovieva SE, Korlukov AA, Sorokin DV, Monzote Fidalgo L, Shchekotikhin AE. Buravchenko GI, et al. Among authors: sorokin dv. Bioorg Chem. 2020 Nov;104:104324. doi: 10.1016/j.bioorg.2020.104324. Epub 2020 Sep 28. Bioorg Chem. 2020. PMID: 33142432
18 results